459 related articles for article (PubMed ID: 29441052)
1. Harnessing the mTOR Pathway for Tuberculosis Treatment.
Singh P; Subbian S
Front Microbiol; 2018; 9():70. PubMed ID: 29441052
[TBL] [Abstract][Full Text] [Related]
2. Host-Directed Therapeutic Strategies for Tuberculosis.
Kolloli A; Subbian S
Front Med (Lausanne); 2017; 4():171. PubMed ID: 29094039
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in
Cerni S; Shafer D; To K; Venketaraman V
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30754665
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
6. Autophagy Induction as a Host-Directed Therapeutic Strategy against
Adikesavalu H; Gopalaswamy R; Kumar A; Ranganathan UD; Shanmugam S
Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34070995
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
[TBL] [Abstract][Full Text] [Related]
8. Autophagy: A new strategy for host-directed therapy of tuberculosis.
Paik S; Kim JK; Chung C; Jo EK
Virulence; 2019 Dec; 10(1):448-459. PubMed ID: 30322337
[TBL] [Abstract][Full Text] [Related]
9. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
de Wet TJ; Warner DF; Mizrahi V
Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
[TBL] [Abstract][Full Text] [Related]
10. Antimycobacterial Effects of Everolimus in a Human Granuloma Model.
Ashley D; Hernandez J; Cao R; To K; Yegiazaryan A; Abrahem R; Nguyen T; Owens J; Lambros M; Subbian S; Venketaraman V
J Clin Med; 2020 Jun; 9(7):. PubMed ID: 32610643
[No Abstract] [Full Text] [Related]
11. Antimycobacterial and Anti-inflammatory Mechanisms of Baicalin via Induced Autophagy in Macrophages Infected with
Zhang Q; Sun J; Wang Y; He W; Wang L; Zheng Y; Wu J; Zhang Y; Jiang X
Front Microbiol; 2017; 8():2142. PubMed ID: 29163427
[TBL] [Abstract][Full Text] [Related]
12. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
Lee HJ; Ko HJ; Kim SH; Jung YJ
PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638
[TBL] [Abstract][Full Text] [Related]
13. Macrophage targeted polymeric curcumin nanoparticles limit intracellular survival of
Gupta PK; Jahagirdar P; Tripathi D; Devarajan PV; Kulkarni S
Front Immunol; 2023; 14():1233630. PubMed ID: 37583694
[TBL] [Abstract][Full Text] [Related]
14. FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy.
Wang J; Sha J; Strong E; Chopra AK; Lee S
Microbiol Spectr; 2022 Oct; 10(5):e0250922. PubMed ID: 36129262
[TBL] [Abstract][Full Text] [Related]
15. Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation.
Ahmed S; Raqib R; Guðmundsson GH; Bergman P; Agerberth B; Rekha RS
Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31936156
[TBL] [Abstract][Full Text] [Related]
16. Targeting Drug-Sensitive and -Resistant Strains of Mycobacterium tuberculosis by Inhibition of Src Family Kinases Lowers Disease Burden and Pathology.
Chandra P; Rajmani RS; Verma G; Bhavesh NS; Kumar D
mSphere; 2016; 1(2):. PubMed ID: 27303736
[TBL] [Abstract][Full Text] [Related]
17. Berbamine promotes macrophage autophagy to clear
Zhang S; Zhou X; Ou M; Fu X; Lin Q; Tao X; Wang Z; Liu A; Li G; Xu Y; Zhang G
mBio; 2023 Aug; 14(4):e0027223. PubMed ID: 37382506
[TBL] [Abstract][Full Text] [Related]
18. Host-Directed Therapies for Tuberculosis.
Jeong EK; Lee HJ; Jung YJ
Pathogens; 2022 Nov; 11(11):. PubMed ID: 36365041
[TBL] [Abstract][Full Text] [Related]
19. Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus.
Zhao L; Fan K; Sun X; Li W; Qin F; Shi L; Gao F; Zheng C
Front Immunol; 2023; 14():1305325. PubMed ID: 38259491
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
